2-hydroxy-5-iodo-4,6-dimethylpyridine-3-carbonitrile, 95.0%, 500mg

(3-(Butylcarbamoyl)-4-chlorophenyl)boronic acid, 95.0%, 25g

5-Bromo-4-fluoro-2-iodopyridine, 97%, 1g

Methyl-PEG24-Amine>95.0%(HPLC)(qNMR)25mg

6-Chloro-3-iodo-1H-pyrazolo[4,3-c]pyridine, 95.0%, 250mg

3,4-Difluoro-2-ethoxyphenylboronic acid, 98%, 500mg

Recipiente de cristalización ROTILABO® sin pico, 150 ml, 80 mm, 10 Unidad(es)

Plato ROTILABO®, 3,0 l, 1 Pieza

(3-Chloro-phenyl)-methanesulfonyl chloride, 95.0%, 1g

Methyl 1H-imidazo[4,5-b]pyridine-6-carboxylate, 95.0%, 1g

Columna capilar GC ROTI®Cap-1701, 25 m, 0,53 mm, 1,00 µm, 1 Pieza(s)

3,5-Difluoro-2-methylsulfanylphenylboronic acid, 98%, 500mg

Vanillyl Alcohol>98.0%(GC)500g